Sometime next year in Japan

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nickk
    Member
    • Nov 2011
    • 65

    Sometime next year in Japan

    A Canadian company has developed first-of-their-kind cell therapies that will, they hope, treat conditions that now affect 1 in 3 Americans: pattern baldness, aging and sun-damaged skin, and chronic tendon degeneration.


    Lee Buckler says next year in Japan and a few more years for US.
  • Thinning87
    Senior Member
    • Dec 2012
    • 839

    #2
    Wow

    This is a huge deal! I don't understand how there haven't been 1000 messages in this thread since its opening. It's not just a rumor, it's the CEO saying this. He surely must be aware what these kind of statements imply for his company so hopefully there is a real chance.

    Finally, I will visit Japan next year.

    Comment

    • BoSox
      Senior Member
      • Jun 2010
      • 697

      #3
      I just read this article this morning. How effective is this treatment? They claim to "put an end to baldness" , they better freaking deliver.

      *Fingers crossed*

      Comment

      • Handbeezy
        Junior Member
        • May 2017
        • 15

        #4
        I was thinking "Ugh, another company just springs up out of nowhere and claims to have the answer, with no clinical trial process? Shut up.", but it's actually Replicel. I didn't see anywhere where the article mentioned 2018 though.

        Comment

        • mrclean
          Senior Member
          • Jan 2017
          • 511

          #5
          They are starting a clinical trial in Europe that will last 3 years so don't think this is next year. I'm trying to get a response from Shiseido on this.

          Comment

          • pkipling
            Inactive
            • Sep 2014
            • 603

            #6
            Interesting. I'm curious if any of you who have been in this field much longer than I have think this seems promising or not. I'm sure there have been countless empty promises made over the years that amounted to nothing. At first glance, does this seem more legit, or just another article/study that won't amount to anything?
            __________________
            I am a patient advocate for Dr. Parsa Mohebi in Los Angeles, CA. My views/opinions are my own and don't necessarily reflect the opinions of Dr. Mohebi and his staff.

            Comment

            • nickk
              Member
              • Nov 2011
              • 65

              #7
              Buckler said the RepliCel’s technology should be available to the general public by sometime next year in Japan, though it may take several more years to see it on the market in the U.S. as clinical trials will still have to be completed here and the data submitted to the FDA,* though the 21st Century Cures Act (Cures Act) may help it along

              Comment

              • GroughBack
                Senior Member
                • Feb 2017
                • 240

                #8
                promising

                Comment

                • tomjones1
                  Junior Member
                  • Nov 2016
                  • 11

                  #9
                  Originally posted by GroughBack
                  promising
                  Anyone have a guess on how much it would cost total for someone in the US to get this done in japan??

                  Comment

                  • Ahab
                    Senior Member
                    • Jul 2014
                    • 142

                    #10
                    Originally posted by nickk
                    Buckler said the RepliCel’s technology should be available to the general public by sometime next year in Japan, though it may take several more years to see it on the market in the U.S. as clinical trials will still have to be completed here and the data submitted to the FDA,* though the 21st Century Cures Act (Cures Act) may help it along
                    Don't count on any fast track from the FDA, especially since many people, even people here, parrot the old canard that baldness isn't serious.

                    Only treatments for serious conditions have a chance to be fast tracked.

                    Comment

                    • Ahab
                      Senior Member
                      • Jul 2014
                      • 142

                      #11
                      Originally posted by nickk
                      https://www.forbes.com/sites/robinse.../#1c7934ce93f2

                      Lee Buckler says next year in Japan and a few more years for US.
                      I didn't see that in the article. What I saw in the article was that in 2016, phase II trials started in Japan.

                      Comment

                      • nickk
                        Member
                        • Nov 2011
                        • 65

                        #12
                        The article is in four parts. Click on yellow arrow for the last pages of the article.

                        Comment

                        • Hairo
                          Junior Member
                          • Mar 2017
                          • 10

                          #13
                          This is massive, does anyone know if having a HT will have a negative impact on the results of replicel?

                          Comment

                          • caddarik79
                            Senior Member
                            • Feb 2013
                            • 495

                            #14
                            Originally posted by Hairo
                            This is massive, does anyone know if having a HT will have a negative impact on the results of replicel?

                            The very most important question... how can we know?
                            has someone tried to get the information?

                            If it is perfectly compatible and the treatment becomes available in one year.. it makes it easy to deal with hair loss...

                            How can we know?

                            Comment

                            Working...